The global osteoporosis drugs market was valued at approximately USD 8.93 billion in 2022 and is expected to grow at a healthy CAGR of more than 3.9% during the forecast period from 2023 to 2030. Osteoporosis is characterized by low bone density and quality, making bones porous and susceptible…
[ad_2]
Source link